24 May 2013
Keywords: alnylam, benitec, agree, deal, rnai, intellectual, property
Article | 25 April 2005
Alnylam Pharmaceuticals, an RNAi therapeutics firm, and fellow US company Benitec, have entered into a licensing agreement over the reciprocal ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.